Low Dose of Diltiazem for Rate Control of Atrial Fibrillation
Information source: Seoul National University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Atrial Fibrillation
Intervention: low dose diltiazem (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Seoul National University Hospital Overall contact:
Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org
Summary
This study is to show the efficacy and safety of low dose diltiazem for the treatment of
atrial fibrillation with rapid ventricular response in emergency room. We will compare the
standard dose of diltiazem(0. 25mg/kg) with low dose diltiazem(0. 1mg/kg)in atrial
fibrillation with rapid ventricular response in ED.
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Success rate of rate control
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- atrial fibrillation with rapid ventricular response in emergency room
Exclusion Criteria:
- age<18
- systolic blood pressure<90mmHg
- no consent
Locations and Contacts
Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org
Seoul National University Hospital, Seoul, Korea, Republic of; Recruiting
Sang Hoon Na, MD, PhD, Phone: +82-2-2072-3047, Email: nasanghoon@gmail.com
Additional Information
Starting date: August 2009
Last updated: July 25, 2011
|
